ARHGEF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.453400E-01
Normal-vs-Stage2
4.531400E-01
Normal-vs-Stage3
1.650590E-01
Normal-vs-Stage4
3.754000E-01
Stage1-vs-Stage2
8.976800E-01
Stage1-vs-Stage3
1.943990E-01
Stage1-vs-Stage4
5.698200E-01
Stage2-vs-Stage3
1.016030E-01
Stage2-vs-Stage4
5.745800E-01
Stage3-vs-Stage4
3.466200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.341600E-01
Normal-vs-AfricanAmerican
3.505600E-01
Normal-vs-Asian
4.353800E-01
Caucasian-vs-AfricanAmerican
6.156400E-01
Caucasian-vs-Asian
9.354000E-01
AfricanAmerican-vs-Asian
6.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.413200E-01
Normal-vs-Female
4.396000E-01
Male-vs-Female
9.671200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.054200E-01
Normal-vs-Age(41-60Yrs)
5.007600E-01
Normal-vs-Age(61-80Yrs)
4.126400E-01
Normal-vs-Age(81-100Yrs)
4.239600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.906600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.491400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.807600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.921600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.042200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.048600E-01
Normal-vs-Daily Drinker
3.433200E-01
Normal-vs-Weekly Drinker
1.506180E-01
Normal-vs-Occasional Drinker
4.435800E-01
Normal-vs-Social Drinker
5.600600E-01
Non Drinker-vs-Daily Drinker
4.089800E-01
Non Drinker-vs-Weekly Drinker
7.397400E-01
Non Drinker-vs-Occasional Drinker
6.612600E-01
Non Drinker-vs-Social Drinker
1.531770E-01
Daily Drinker-vs-Weekly Drinker
3.027200E-01
Daily Drinker-vs-Occasional Drinker
2.005600E-01
Daily Drinker-vs-Social Drinker
2.531800E-02
Weekly Drinker-vs-Occasional Drinker
9.674200E-01
Weekly Drinker-vs-Social Drinker
3.409000E-01
Occasional Drinker-vs-Social Drinker
2.629200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.339500E-02
Normal-vs-Grade 2
5.782200E-04
Normal-vs-Grade 3
1.575260E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.731400E-01
Grade 1-vs-Grade 3
7.993600E-01
Grade 1-vs-Grade 4
2.339500E-02
Grade 2-vs-Grade 3
6.383400E-01
Grade 2-vs-Grade 4
5.782200E-04
Grade 3-vs-Grade 4
1.575260E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.910000E-01
Normal-vs-NonDiabetic
4.547000E-01
Diabetic-vs-NonDiabetic
2.238800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.621400E-01
Normal-vs-NoPancreatitis
4.276600E-01
Pancreatitis-vs-NoPancreatitis
7.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.077800E-01
Normal-vs-N1
4.524400E-01
N0-vs-N1
3.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.594800E-01
Normal-vs-TP53-NonMutant
9.119700E-02
TP53-Mutant-vs-TP53-NonMutant
6.222600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
